Importantly, both types of inhibitors reduce the abundance of the Myc protein and inhibit the proliferation of several human cancer cell lines where they provoke an energy crisis that is marked by ATP depletion, neutral lipid accumulation, AMPK (adenosine monophosphate-activated protein kinase) activation, cell-cycle arrest, and apoptosis [96]. The gene discussed is MYC; the disease is cancer.